Biotin and Nephrogenic anaemia - a phase IV clinical study of FDA data

Summary:

Nephrogenic anaemia is reported as a side effect among people who take Biotin (biotin), especially for people who are female, 60+ old, have been taking the drug for 5 - 10 years also take Nexium, and have Gastroesophageal reflux disease.

The phase IV clinical study analyzes which people have Nephrogenic anaemia when taking Biotin. It is created by eHealthMe based on reports of 33,728 people who have side effects when taking Biotin from the FDA, and is updated regularly.

What is Biotin?

Biotin has active ingredients of biotin. It is often used in hair loss. eHealthMe is studying from 35,393 Biotin users. Check the latest studies of Biotin.

What is Nephrogenic anaemia?

Nephrogenic anaemia (anaemia due to kidney disease) is found to be associated with 874 drugs and 496 conditions by eHealthMe. Check the latest studies of Nephrogenic anaemia.

On Jul, 14, 2026

33,728 people reported to have side effects when taking Biotin.
Among them, 70 people (0.21%) have Nephrogenic anaemia.

Among these 70 people:

How long have people been on Biotin when they have Nephrogenic anaemia? *

What is the gender of people who have Nephrogenic anaemia when taking Biotin? *

female: 89.86 %
male: 10.14 %

What is the age of people who have Nephrogenic anaemia when taking Biotin? *

What are other drugs people take besides Biotin? *

What are other side effects people have besides Nephrogenic anaemia? *

Chronic Kidney Disease: 70 people, 100.00%
Acute Kidney Failure: 60 people, 85.71%
Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 25 people, 35.71%
Interstitial Nephritis (inflammation of the kidney): 15 people, 21.43%
Renal Injury (kidney injury): 14 people, 20.00%
Renal Impairment (severely reduced kidney function): 13 people, 18.57%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 10.00%
Depression: 7 people, 10.00%
Nephropathy (damage to or disease of a kidney): 7 people, 10.00%
Renal Tubular Necrosis (death of kidney tubules): 5 people, 7.14%

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 61 people, 87.14%
Pain: 35 people, 50.00%
High Blood Cholesterol: 25 people, 35.71%
High Blood Pressure: 22 people, 31.43%
Infection: 20 people, 28.57%
Depression: 14 people, 20.00%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 12 people, 17.14%
Diabetes: 12 people, 17.14%
Inflammation: 11 people, 15.71%
Indigestion: 10 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Biotin and have Nephrogenic anaemia?

- Check whether Nephrogenic anaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Biotin:

Biotin (35,393 reports)

Browse all side effects of Biotin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nephrogenic anaemia:

Nephrogenic anaemia (874 drugs)

Browse all the conditions that are associated with Nephrogenic anaemia:

Nephrogenic anaemia (496 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on biotin (the active ingredients of Biotin) and Biotin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.